In summary, we constructed a risk assessment model of five CD4+ MTC-related gene markers for COAD and drew the nomogram of the hub gene and clinical independent risk factors to assess immunotherapy efficacy, disease prognosis, and survival time of the patient. Here, CD4 is linked to medullary thyroid gland carcinoma.